Maxifed
- Product NDC
- 58605-101
- 11-digit product format
- 586050101
- Labeler code
- 58605
- Product ID
- 58605-101_f954e296-1429-4985-9d04-a20b67e2cf71
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- GUAIFENESIN and Pseudoephedrine Hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- MCR American Pharmaceuticals, Inc.
- Application
- part341
- Marketing category
- OTC MONOGRAPH FINAL
- Marketing start
- 2018-04-01
- Marketing end
- 0000-00-00
- Substance
- GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE
- Active strength
- 360 mg/1; mg/1
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 58605-101-01 | Maxifed | 100 in 1 BOTTLE, PLASTIC | TABLET | 100 | | 1 |
| 58605-101-20 | Maxifed | 20 in 1 BLISTER PACK | TABLET | 20 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 58605-101 | MAXIFED (GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE) TABLET [MCR AMERICAN PHARMACEUTICALS, INC.] | 1 | Legacy NDC, 2 package rows | 20180401_8a1be614-2a78-4899-9697-774479f2daa5.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 58605-101-01 | 58605010101 | 100 TABLET in 1 BOTTLE, PLASTIC (58605-101-01) | 100 tablet | 2018-04-01 | 0000-00-00 | No | No | Current |
| 58605-101-20 | 58605010120 | 20 TABLET in 1 BLISTER PACK (58605-101-20) | 20 tablet | 2018-04-01 | 0000-00-00 | Yes | No | Current |